New PET tracer could reveal how well breast cancer treatment works
NCT ID NCT06502691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new radioactive tracer called [18F]FTT to see if it can help doctors see how well standard treatments are working in people with metastatic breast cancer. The tracer attaches to a protein in cancer cells and shows up on a PET scan. About 22 participants will get the tracer and a PET scan while receiving their usual care. The goal is to learn whether this imaging method can tell apart people whose cancer responds to treatment from those whose cancer does not.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fred Hutch/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Engineered immune cells join chemo and antibody to attack Hard-to-Treat breast cancer
- Could a gentler chemo work for older breast cancer patients?
- Genetic clues in blood and tumors could personalize breast cancer care
- Can couples coping together ease the burden of advanced cancer?
- Blood test could track breast cancer in real time